Phase 3 Trials at Kidney Week 2026 Show New Promise for IgA Nephropathy Care
Phase 3 trial results presented at ASN Kidney Week 2026 show that atacicept, sibeprenlimab and telitacicept provided kidney protection for ...
Tag: atacicept
POPULAR NEWS
-
Generative AI Enters Early Childhood Assessment Faster Than Research Can Follow
-
Nearly Half of Patients with Behçet’s Disease Report Depression or Anxiety
-
Subcutaneous Infliximab Could Cut Jordan’s Autoimmune Disease Treatment Costs
-
Platform Trials Promise Faster Answers but Face Serious Methodological Pitfalls